<DOC>
	<DOCNO>NCT02063360</DOCNO>
	<brief_summary>The purpose study determine interaction healthy subject take BMS-663068 Darunavir/Ritonavir and/or Etravirine .</brief_summary>
	<brief_title>DDI Study BMS-663068 With Etravirine ( ETR ) and/or Darunavir ( DVR ) + Ritonavir ( RTV )</brief_title>
	<detailed_description>Brief title : drug-drug interaction ( DDI ) Primary Purpose : Other : Phase 1 Clinical Pharmacology drug interaction study healthy subject</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<mesh_term>Etravirine</mesh_term>
	<criteria>Healthy subject clinically significant deviation normal medical history , physical examination finding , 12lead ECG measurement , clinical laboratory test Women childbearing potential ( WOCBP ) allow . Must practice highly effective method contraception Any significant acute chronic medical condition Unable tolerate oral medication Inability venipunctured and/or tolerate venous access Current recent ( within 3 month dose ) gastrointestinal disease Abnormal liver function test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>